FDA Approves Johnson & Johnson’s Prezista For HIV-Positive People Who Have Never Taken Antiretrovirals

FDA on Tuesday approved Johnson & Johnson’s protease inhibitor Prezista for use by people who have never taken antiretroviral drugs in the past, the Wall Street Journal reports. FDA in 2006 approved Prezista for HIV-positive people who had developed resistance to other drugs.

More: continued here

Filed under: HIV / AIDS on October 27th, 2008